Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 102-106, January 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J. H.
Right arrow Articles by Young, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J. H.
Right arrow Articles by Young, C. W.

Quercetin, an Inhibitor of Lactate Transport and a Hyperthermic Sensitizer of HeLa Cells1

Jae Ho Kim, Sang Hie Kim, Alan A. Alfieri and Charles W. Young

Departments of Radiation Therapy and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

Since cancer cells produce large amounts of lactate via aerobic glycolysis and since an acidic pH has been shown to selectively enhance the cytotoxic effects of hyperthermia, we are examining the influence of cell exposure to drugs which inhibit lactate transport and lower intracellular pH upon cytotoxic effects of hyperthermia. Quercetin, a bioflavonoid that produces lactate transport inhibition, was not cytotoxic up to 4 hr at 37° (0.1 mM). When HeLa cells were exposed to quercetin at 41 and 42°, significant potentiation of hyperthermia-induced cytotoxicity was observed. The magnitude of the potentiation was dependent on the drug concentration, pH of the culture medium, temperature, and duration of treatment. In contrast, treatment of cells with rutin, a structurally related bioflavonoid that lacks the property of lactate transport inhibition, showed no hyperthermic potentiation.

1 Supported in part by National Cancer Institute Grant CA-33894.

Received 4/25/83. Accepted 9/28/83.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
R. A. Coss, C. W. Storck, C. Daskalakis, D. Berd, and M. L. Wahl
Intracellular Acidification Abrogates the Heat Shock Response and Compromises Survival of Human Melanoma Cells
Mol. Cancer Ther., April 1, 2003; 2(4): 383 - 388.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. L. Wahl, J. A. Owen, R. Burd, R. A. Herlands, S. S. Nogami, U. Rodeck, D. Berd, D. B. Leeper, and C. S. Owen
Regulation of Intracellular pH in Human Melanoma: Potential Therapeutic Implications
Mol. Cancer Ther., June 1, 2002; 1(8): 617 - 628.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.